Pipeline of Progress: Epilepsy Medications on the Horizon
April 8 @ 4:00 pm - 5:00 pm
Join us for the first event in our Pipeline of Progress series, created especially for people living with epilepsy and the loved ones who support them. This interactive webinar will help you understand what new treatments are on the horizon and what researchers are working on right now.
Our speaker, Dr. Fountain, is a highly respected epileptologist and a leader in clinical trials. He’ll walk you through epilepsy medications in Phase 3 trials, exciting ideas scientists are exploring, and a few promising treatments that may be getting closer to approval. We’ll also have a moderated Q&A, where you can ask questions in a safe and welcoming space.
Speaker
Dr. Nathan Fountain, Virginia School of Medicine
Nathan B. Fountain, MD, holds the Thomas E. Worrell, Jr. Professorship of Neurology and Epileptology at the University of Virginia School of Medicine, where he has served as the Director of the F.E. Dreifuss Comprehensive Epilepsy Program since 1998. He completed neurology residency and specialized fellowships in clinical epilepsy and epilepsy research at the University of Virginia.
His clinical practice is dedicated to the comprehensive diagnosis of all forms of epilepsy and making available all forms of management including medications, surgery, and neuromodulation devices. For patients who feel they have exhausted standard treatments, Dr. Fountain’s team offers the option to participate in clinical trials. His research in clinical trials for new anti-seizure medications and innovative medical devices provides patients access to new therapies before they are generally available, and the opportunity to contribute to help find new treatments for others with epilepsy.